1440519-80-1 Usage
General Description
5H-Pyrrolo[3,4-b]pyridin-5-one, 6,7-dihydro-2-Methoxy-7,7-diMethyl- is a chemical compound with a complex molecular structure. It has a pyrrolopyridinone core with a 2-methoxy-7,7-dimethyl substituent. 5H-Pyrrolo[3,4-b]pyridin-5-one, 6,7-dihydro-2-Methoxy-7,7-diMethyl- is a heterocyclic organic molecule with potential applications in the field of medicinal chemistry and drug development. Its specific properties and potential uses in various industrial and scientific applications would need to be further studied and determined. Additionally, its synthesis, purification, and characterization would also be important aspects to consider in its utilization.
Check Digit Verification of cas no
The CAS Registry Mumber 1440519-80-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,0,5,1 and 9 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1440519-80:
(9*1)+(8*4)+(7*4)+(6*0)+(5*5)+(4*1)+(3*9)+(2*8)+(1*0)=141
141 % 10 = 1
So 1440519-80-1 is a valid CAS Registry Number.
1440519-80-1Relevant articles and documents
SPIRODIAMINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS
-
Page/Page column 47, (2016/05/02)
The invention provides compounds having the general formula (I) pharmaceutical compositions containing the compounds and a process for their preparation. The compounds act as aldosterone synthase inhibitors and are for use in the treatment or prevention of chronic kidney disease, congestive heart failure, hypertension, primary aldosteronism and Cushing syndrom.
NEW BICYCLIC DIHYDROISOQUINOLINE-1-ONE DERIVATIVES
-
Page/Page column 156; 157, (2013/06/27)
The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4? R5, R6, A1, A2, A3, A4, A5 and n are as described herein,compositions including the compounds and methods of using the compounds as aldosterone synthase (CYP11B2 or CYP11B1) inhibitors for the treatment or prophylaxis of chronic kidney disease, congestive heart failure, hypertension, primary aldosteronism and Cushing syndrom.
